The dapagliflozin and prevention of adverse outcomes in chronic kidney disease: results of the DAPA-CKD study

Batyushin, MM

Batyushin, MM (corresponding author), Rostov State Med Univ, Rostov Na Donu, Russia.

TERAPEVTICHESKII ARKHIV, 2021; 93 (6): 713

Abstract

Aim. The article presents the main results of a randomized, double-blind, parallel, placebo - controlled trial of DAPA-CKD. Materials and methods. The......

Full Text Link